Oppenheimer set a $120.00 target price on Neurocrine Biosciences (NASDAQ:NBIX) in a report published on Monday morning. The brokerage currently has a buy rating on the stock. Oppenheimer also issued estimates for Neurocrine Biosciences’ FY2021 earnings at $7.03 EPS and FY2022 earnings at $7.88 EPS.
Several other research analysts have also commented on the company. ValuEngine raised Neurocrine Biosciences from a hold rating to a buy rating in a research report on Monday, April 2nd. BidaskClub downgraded Neurocrine Biosciences from a strong-buy rating to a buy rating in a research note on Tuesday, March 20th. Leerink Swann boosted their target price on Neurocrine Biosciences from $90.00 to $96.00 and gave the stock an outperform rating in a research note on Tuesday, February 20th. JPMorgan Chase boosted their target price on Neurocrine Biosciences from $79.00 to $100.00 and gave the stock an overweight rating in a research note on Wednesday, February 14th. Finally, Barclays restated an overweight rating and set a $100.00 target price on shares of Neurocrine Biosciences in a research note on Wednesday, February 14th. Thirteen analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. The company currently has a consensus rating of Buy and a consensus price target of $102.77.
Top 5 Value Stocks To Buy For 2018: KKR(KKR)
Advisors’ Opinion:
- [By ]
Kohlberg Kravis Roberts (KKR) : “I’m a buyer. I’ve respected them for generations. “
Mitek Systems (MITK) : “This one is too speculative for me. I’d buy NVIDIA (NVDA) .”
- [By Wayne Duggan]
On this day 39 years ago, KKR & Co. L.P. Unit (NYSE: KKR) completed the first modern leveraged buyout of a public company, taking over manufacturer Houdaille Industries for $355 million.
- [By ]
In the Lightning Round, Cramer was bullish on Spotify (SPOT) , Alkermes (ALKS) , Johnson & Johnson (JNJ) , Thermo Fisher Scientific (TMO) , Sorrento Therapeutics (SRNE) , NVIDIA (NVDA) , Nucor, Eli Lilly (LLY) and Kohlberg Kravis Roberts (KKR) .
- [By Motley Fool Staff]
KKR (NYSE:KKR) Q1 2018 Earnings Conference CallMay. 3, 2018 11:00 a.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:Operator
Top 5 Value Stocks To Buy For 2018: Steelcase Inc.(SCS)
Advisors’ Opinion:
- [By Logan Wallace]
Here are some of the media stories that may have impacted Accern’s rankings:
Get Steelcase alerts:
Vida Health Expands Platform to Tackle Comorbidities (prweb.com) Zacks: Brokerages Expect Steelcase (SCS) Will Announce Quarterly Sales of $756.45 Million (americanbankingnews.com) Knoll: Q1 Earnings Enough To Stay Long (seekingalpha.com) ValuEngine Downgrades Steelcase (SCS) to Sell (americanbankingnews.com) Should Stem Cells Spin SA.s (WSE:SCS) Recent Earnings Decline Worry You? (finance.yahoo.com)
Several research analysts have weighed in on the company. ValuEngine lowered Steelcase from a “hold” rating to a “sell” rating in a research report on Wednesday, May 2nd. Seaport Global Securities reaffirmed a “neutral” rating on shares of Steelcase in a research report on Monday, March 26th. Finally, Zacks Investment Research raised Steelcase from a “sell” rating to a “hold” rating in a research report on Wednesday, March 28th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $16.00.
- [By Stephen Mack]
Jim Hackett spent two decades as CEO of Michigan-based office furniture company Steelcase Inc. (NYSE: SCS). When he took over, the American workplace was shifting away from cubicles, and the company looked on the verge of extinction, with $70 million in annual losses.
- [By Ethan Ryder]
SpeedCash (CURRENCY:SCS) traded 13.6% lower against the dollar during the 1 day period ending at 10:00 AM ET on May 4th. One SpeedCash coin can now be purchased for approximately $2.71 or 0.00028080 BTC on major exchanges including YoBit, Cryptohub, Trade Satoshi and Crex24. During the last seven days, SpeedCash has traded 201.8% higher against the dollar. SpeedCash has a total market capitalization of $1.26 million and $26,755.00 worth of SpeedCash was traded on exchanges in the last 24 hours.
- [By Max Byerly]
SpeedCash (SCS) is a coin. SpeedCash’s total supply is 476,918 coins and its circulating supply is 467,791 coins. The Reddit community for SpeedCash is /r/SpeedCash and the currency’s Github account can be viewed here. SpeedCash’s official Twitter account is @SpeedCashMedia. SpeedCash’s official website is www.scash.ml.
Top 5 Value Stocks To Buy For 2018: Two Harbors Investments Corp(TWO)
Advisors’ Opinion:
- [By Lisa Levin] Gainers
Genprex, Inc. (NASDAQ: GNPX) shares gained 86.76 percent to close at $11.00 on Thursday.
Comstock Resources, Inc. (NYSE: CRK) shares climbed 47.06 percent to close at $7.00 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes.
Ceridian HCM Holding Inc. (NASDAQ: CDAY) gained 41.86 percent to close at $31.21.
MarineMax, Inc. (NYSE: HZO) shares rose 26.5 percent to close at $22.20 as the company posted upbeat Q2 results and raised its FY18 outlook.
Concord Medical Services Holdings Limited (NYSE: CCM) jumped 24.92 percent to close at $4.06.
Mattersight Corporation (NASDAQ: MATR) shares climbed 23.26 percent to close at $2.65 after the company agreed to be purchased by NICE Ltd.
Chipotle Mexican Grill, Inc. (NYSE: CMG) rose 24.44 percent to close at $422.50 as the company reported stronger-than-expected results for its first quarter on Wednesday.
Ultra Clean Holdings, Inc. (NASDAQ: UCTT) gained 17.75 percent to close at $18.64 following upbeat Q1 earnings.
PCM, Inc. (NASDAQ: PCMI) rose 16.59 percent to close at $12.30 following Q1 results.
Zymeworks Inc. (NASDAQ: ZYME) rose 16.06 percent to close at $15.25.
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares climbed 14.5 percent to close at $121.42 as the company posted reported Q1 beat And raised FY18 outlook.
Advanced Micro Devices, Inc. (NASDAQ: AMD) shares gained 13.7 percent to close at $11.04 as the company reported upbeat results for its first quarter.
Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 13.21 percent to close at $3.00 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
O'Reilly Automotive, Inc. (NASDAQ: ORLY) jumped 13.06 percent to close at $257.40 following upbeat Q1 profit.
BioTelemetry, - [By Logan Wallace]
HL Financial Services LLC purchased a new position in shares of Two Harbors Investment (NYSE:TWO) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 53,436 shares of the real estate investment trust’s stock, valued at approximately $821,000.
- [By Matthew Frankel]
Mortgage real estate investment trust CYS Investments (NYSE:CYS) announced today that it had agreed to be acquired by fellow mortgage REIT Two Harbors Investment (NYSE:TWO).
Top 5 Value Stocks To Buy For 2018: Interactive Brokers Group, Inc.(IBKR)
Advisors’ Opinion:
- [By Dustin Blitchok]
The European Union’s General Data Protection Regulation takes effect May 25, and Steve Sanders, the executive vice president of marketing and product development at Interactive Brokers (NASDAQ: IBKR), described it as the “bane of my existence.” Compliance with the regulations is taking resources from other products at the online brokerage, he said.
Top 5 Value Stocks To Buy For 2018: Immersion Corporation(IMMR)
Advisors’ Opinion:
- [By Lisa Levin] Gainers
MoSys, Inc. (NASDAQ: MOSY) shares rose 44.7 percent to $2.20 in pre-market trading after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
The Trade Desk, Inc. (NASDAQ: TTD) rose 23.2 percent to $65.01 in pre-market trading after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
Immersion Corporation (NASDAQ: IMMR) rose 17 percent to $13.55 in pre-market trading after reporting upbeat Q1 results.
Akcea Therapeutics, Inc. (NASDAQ: AKCA) rose 13.8 percent to $23.50 in pre-market trading after the company disclosed that the FDA Advisory Committee voted in favor of WAYLIVRA for the treatment of familial chylomicronemia syndrome.
RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 9.4 percent to $2.45 in pre-market trading after the company disclosed a collaboration with Iovance Biotherapeutics.
ViewRay, Inc. (NASDAQ: VRAY) rose 13.7 percent to $8.80 in pre-market trading after reporting upbeat quarterly earnings.
ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 5.6 percent to $32.00 in pre-market trading after falling 2.26 percent on Thursday.
Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 5.6 percent to $9.30 in pre-market trading after reporting Q3 results.
Aflac Incorporated (NYSE: AFL) rose 4.7 percent to $47.50 in pre-market trading.
Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 4.2 percent to $2.24 in pre-market trading following Q1 earnings.
Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) shares rose 3.7 percent to $11.00 in pre-market trading after the company reported Q1 earnings.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
- [By Lisa Levin] Gainers
The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results.
MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39.
Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval.
Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results.
ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings.
Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million.
Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results.
Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results.
VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71.
Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results.
Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results.
Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results.
Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739.
Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69 - [By Stephan Byrd]
Wells Fargo & Company MN reduced its stake in shares of Immersion Co. (NASDAQ:IMMR) by 67.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 18,010 shares of the software maker’s stock after selling 36,839 shares during the quarter. Wells Fargo & Company MN owned approximately 0.06% of Immersion worth $127,000 at the end of the most recent quarter.
- [By Shane Hupp]
Shares of Immersion Co. (NASDAQ:IMMR) reached a new 52-week high and low during trading on Friday following a stronger than expected earnings report. The stock traded as low as $13.05 and last traded at $12.34, with a volume of 86458 shares trading hands. The stock had previously closed at $13.21.
- [By Shane Hupp]
Here are some of the news headlines that may have impacted Accern’s analysis:
Get Immersion alerts:
Turtle Beach (HEAR) and Immersion (IMMR) Are Aggressive Growth Stocks (finance.yahoo.com) Immersion (IMMR) Stock Rating Upgraded by Zacks Investment Research (americanbankingnews.com) Is the Options Market Predicting a Spike in Immersion (IMMR) Stock? (zacks.com) Immersion (IMMR) vs. Radisys (RSYS) Head-To-Head Review (americanbankingnews.com) Stock Traders Purchase High Volume of Immersion Put Options (IMMR) (americanbankingnews.com)
Immersion opened at $13.76 on Friday, according to Marketbeat. Immersion has a 12 month low of $13.32 and a 12 month high of $13.55. The firm has a market cap of $422.28 million, a P/E ratio of -11.56, a P/E/G ratio of 0.53 and a beta of 1.22.
